The Arg389Gly beta1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test

Europace. 2007 Aug;9(8):585-8. doi: 10.1093/europace/eum059. Epub 2007 Apr 26.

Abstract

Aims: To investigate the association of the Gly389 allele with positive head-up tilt test (HUT) in a Mexican Mestizo population.

Methods and results: HUT results were compared between carriers (one or two copies of the Gly389 allele) and non-carriers (Arg389Arg genotype) of the Gly389 allele of the beta(1)AR gene in 50 patients with unexplained syncope. Thirty-three patients (66%) had a positive HUT. Patients with a positive HUT had a higher Gly389 allele frequency compared with those with a negative test (30.3 vs. 3%; OR 13; pC = 0.012). Moreover, when comparing positive HUT in passive drug-free phase, positive HUT in pharmacological (nitrate) phase, and negative (both phases), a decreasing gradient in the frequencies of the Gly389 allele was found among the three groups: 45.4, 22.7, and 3%, respectively.

Conclusion: An association of positive tilt table testing to a single nucleotide polymorphism with a Gly to Arg switch at position 389 of the beta(1)AR was found. This polymorphism may contribute to susceptibility to faint during orthostatic challenge.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Heterozygote
  • Humans
  • Male
  • Mexico / epidemiology
  • Mutation
  • Polymorphism, Single Nucleotide / genetics*
  • Receptors, Adrenergic, beta-1 / genetics*
  • Syncope / diagnosis
  • Syncope / epidemiology*
  • Syncope / genetics*
  • Tilt-Table Test / statistics & numerical data*

Substances

  • Receptors, Adrenergic, beta-1